TMCnet News

Global Neuropathy Pain Treatment Market to Grow at a CAGR of 5.8% by 2021 - Increasing Mergers & Acquisitions Would Lead to Further Consolidation - Research and Markets

[March 28, 2017]

Global Neuropathy Pain Treatment Market to Grow at a CAGR of 5.8% by 2021 - Increasing Mergers & Acquisitions Would Lead to Further Consolidation - Research and Markets

Research and Markets has announced the addition of the "Global Neuropathy Pain Treatment Market 2017-2021" report to their offering.

The global neuropathy pain treatment market to grow at a CAGR of 5.85% during the period 2017-2021.

The report, Global Neuropathy Pain Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one driver in market is presence of large patient pool. The presence of large patient pool with neuropathic pain is expected to fuel the market growth. Neuropathic pain is associated with various disorders such as diabetic neuropathy, chemotherapy-induced pain, shingles, and herniated disk. There has been growing cases of the population with these isorders. For instance, according to the CDC 2014 statistics, 29.1 million individuals in the US have diabetes in 2014. Out of this, around 6-7 individuals per 1,000 individuals are suffering from diabetic neuropathy. Also, the increasing individuals referring chemotherapy for cancer treatment is fueling the cases of chemotherapy-induced pain.

Key vendors